Cove Street Capital’s Phibro Animal Health PAHC Stock Holding History

Cove Street Capital’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40,000	Closed	-$817K	–	90
2021 Q4	$817K	Sell	40,000 -51,761	-56%	-$1.11M	0.14%	61
2021 Q3	$1.98M	Sell	91,761 -121,616	-57%	-$2.93M	0.29%	51
2021 Q2	$6.16M	Sell	213,377 -486,655	-70%	-$13.2M	0.89%	33
2021 Q1	$17.1M	Buy	700,032 +71,251	+11%	+$1.61M	2.45%	16
2020 Q4	$12.2M	Buy	628,781 +5,420	+0.9%	+$99.7K	2.16%	18
2020 Q3	$10.8M	Buy	623,361 +122,488	+24%	+$2.61M	2.05%	18
2020 Q2	$13.2M	Sell	500,873 -97,717	-16%	-$2.43M	2.6%	13
2020 Q1	$14.5M	Buy	598,590 +3,293	+0.6%	+$80.5K	2.96%	12
2019 Q4	$14.8M	Buy	595,297 +9,241	+2%	+$214K	1.95%	20
2019 Q3	$12.5M	Buy	586,056 +364,200	+164%	+$9.98M	1.75%	24
2019 Q2	$7.05M	Buy	+221,856	New	+$6.96M	0.91%	37

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cove Street Capital's PAHC Position: Q1 2022 in Review

Cove Street Capital sold out of Phibro Animal Health (PAHC) in Q1 2022, closing a stake of 40,000 shares — an estimated $817K sold.

Cove Street Capital first reported a position in PAHC in Q2 2019 and held it in 11 quarters. The position peaked at $17.1M in Q1 2021. 153 funds tracked by Wall St. Rank hold PAHC as of Q1 2022.

Cove Street Capital reported no remaining Phibro Animal Health position as of Q1 2022 after selling out during the quarter.
Cove Street Capital sold 40,000 Phibro Animal Health shares in Q1 2022, an estimated $817K.
Cove Street Capital first reported a position in Phibro Animal Health in Q2 2019 and held it in 11 quarters.
Cove Street Capital's Phibro Animal Health position peaked at $17.1M in Q1 2021.
153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2022.

Based on Cove Street Capital's 13F filing for Q1 2022, filed 2 May 2022.